Central Vein Catheters for Hemodialysis

Almirall, Jaume; Campistol, Josep M.; Rello, Jordi; Ponz, Esther; Revert, L

doi:10.1159/000185311

Cited by 3 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For these reasons, subclavian cannulation should be avoided in patients with pulmonary dysfunction or pulmonary edema. Accidental puncture of the subclavian artery occurs in approximately 1 to 4% of patients (2,13). This complication can lead to a massive hemothorax and extensive bleeding requiring transfusion whereas a delay in performing hemodialysis with heparin of at least 24 h is compulsory.…”

Section: Insertion Complicationsmentioning

confidence: 99%

Subclavian Vein Hemodialysis Catheters: Advantages and Disadvantages

1994

View full text Add to dashboard Cite

The pros and cons of subclavian vein hemodialysis catheters are reviewed. The subclavian vein catheter offers rapid and adequate vascular access. Other advantages are preservation of patient mobility and the ease with which the dressing can be secured. In contrast, subclavian vein stenosis has recently been identified as an important long-term complication of subclavian vein catheters that seriously compromises the creation and long-term viability of later ipsilateral arteriovenous fistulas. For this reason, we recommend restricting use of the subclavian hemodialysis catheter for acute situations and preferential use of internal jugular catheters for more chronic approaches because they better preserve venous integrity.

show abstract

Section: Insertion Complicationsmentioning

confidence: 99%

Subclavian Vein Hemodialysis Catheters: Advantages and Disadvantages

1994

View full text Add to dashboard Cite

show abstract

“…Although pulmonary embolism complicating central venous catheter has been reported in other situations [1][2][3], pulmonary embolism relating to the use of central venous catheter for hemodialysis is rare [4][5][6]. Unfractionated heparin (UFH) given intravenously followed by oral anti-coagulant therapy is generally accepted as the treatment of choice for most patients with minor and submassive pulmonary embolism [7][8][9][10][11][12].…”

Section: Introductionmentioning

confidence: 99%

Treatment of Pulmonary Embolism by Subcutaneous Low-Molecular- Weight Heparin in a Hemodialysis Patient

Szeto

Wang²,

Lui³

et al. 1998

Am J Nephrol

View full text Add to dashboard Cite

Low-molecular-weight heparin (LMWH) has been used in the prophylaxis and treatment of deep vein thrombosis. Data regarding the efficacy of this drug without subsequent use of oral anticoagulant in the treatment of pulmonary embolism is limited. Pulmonary embolism may complicate the use of central venous catheter in hemodialysis. We report a case of acute submassive pulmonary embolism complicating a central venous hemodialysis catheter in a dialysis patient. After the catheter was removed, the patient was treated successfully with subcutaneous injection of LMWH for three months. We conclude that LMWH is safe and effective for treatment of pulmonary embolism in patient on hemodialysis.

show abstract

Pulmonary Embolism Due to an Indwelling Central Venous Catheter

Rello

1991

Chest

View full text Add to dashboard Cite

Central Vein Catheters for Hemodialysis

Cited by 3 publications

References 0 publications

Subclavian Vein Hemodialysis Catheters: Advantages and Disadvantages

Subclavian Vein Hemodialysis Catheters: Advantages and Disadvantages

Treatment of Pulmonary Embolism by Subcutaneous Low-Molecular- Weight Heparin in a Hemodialysis Patient

Pulmonary Embolism Due to an Indwelling Central Venous Catheter

Contact Info

Product

Resources

About